Top Markets
Coin of the day
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Rang in aandelen #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Aandeelprijs
$0.069
Laatst gesynchroniseerd: 2024-07-22
Marktkapitalisatie
$2.06M
Verandering (1 dag)
-1.43%
Verandering (1 jaar)
0.00%
Land
US
Handel DermTech, Inc. (DMTK)

Categorie

EPS voor DermTech, Inc. (DMTK)
EPS per March 2024 TTM: $-2.70
Volgens de laatste financiële rapporten en de aandelenkoers van DermTech, Inc. is de huidige EPS van het bedrijf (TTM) $-2.70. Eind 2022 had het bedrijf een EPS van $-3.88, een stijging ten opzichte van de EPS van 2021 die $-2.71 bedroeg.
EPS-geschiedenis van DermTech, Inc. van 2012 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
2026 (TTM) $-2.70 -12.62%
2023 $-3.09 -20.36%
2022 $-3.88 43.17%
2021 $-2.71 32.20%
2020 $-2.05 -34.50%
2019 $-3.13 -969.44%
2018 $0.36 0.00%
2017 0.00 -100.00%
2013 $-1.10 69.23%
2012 $-0.65 0.00%
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
$18.62 -789.63%
US
$5.65 -309.26%
US
- -
CN
$-1.36 -49.63%
US
$14.24 -627.41%
US